Brief: Stereotaxis To Initiate First-In-Human Trial To Support CE Mark Application Of Magic Catheter
15/06/2023 22:05
June 15 (Reuters) - Stereotaxis Inc STXS.A :
* STEREOTAXIS TO INITIATE FIRST-IN-HUMAN TRIAL TO SUPPORT CE
MARK
APPLICATION OF MAGIC CATHETER
* STEREOTAXIS INC - REITERATES ITS EXPECTATION OF
DOUBLE-DIGIT
REVENUE GROWTH IN 2023
Source text for Eikon: ID:nGNXcbkBSm
Further company coverage: STXS.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stereotaxis
See all newsSurgical robotics provider Stereotaxis' Q1 revenue misses analyst estimates
Stereotaxis rises after FDA clears new heart-procedure platform
Surgical robotics firm Stereotaxis Q4 revenue jumps
Brief: Stereotaxis Q4 Revenue USD 8.642 Million
Brief: Stereotaxis Receives FDA Approval For Magic Ablation Catheter